Skip to NavigationSkip to content

Recipharm announces closing of acquisitions of two major CDMOs

Published on 11/04/22 at 10:28am

Recipharm has announced the closing of its acquisitions of advanced therapy CDMO Arranta Bio and virotherapy CDMO Vibalogics.

The acquisitions showcase Recipharm’s strategy of cementing its presence in the Biologics market, with a particular focus on drug substance manufacturing of novel ATMPs (advanced therapy medicinal products). They follow Recipharm’s entry into biologics earlier this year with the acquisition of Portuguese company GenIbet.

These acquisitions also enable Recipharm to establish a strong base in the US, with facilities in Boxborough, MA, and provides a platform to build its capabilities in new biologics modalities.

Marc Funk, CEO of Recipharm, said: "This acquisition is an important step in growing our Biologics business and developing our US presence. We will be building on the pioneering excellence which lies at the heart of these companies and providing drug developers in the Biologics market with scientifically differentiated CDMO services and expertise for ATMPs.

These deals, together with our recent acquisition of GenIbet, a specialist in the manufacture of biological clinical material, mean that we will be well placed to develop new capabilities in innovative technologies across gene therapy, viral vectors, mRNA/ plasmids, oncolytic virus and microbiome.

I would also like to take this opportunity to congratulate Mark on his achievements in building the Arranta Bio operation so successfully. I am looking forward to working with both David as he takes over the leadership at Arranta Bio, and with Tom Hochuli at Vibalogics as we move into the next exciting phase of our combined growth.

We are thrilled to be closing both acquisitions and look forward to welcoming the Arranta Bio and Vibalogics teams into the Recipharm organisation."

Lina Adams

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches